OptimizeRx Corp (NASDAQ: OPRX) started the day on Wednesday, with a price increase of 5.31% at $6.15, before settling in for the price of $5.84 at the close. Taking a more long-term approach, OPRX posted a 52-week range of $5.04-$16.65.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 30.00%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 33.94%. This publicly-traded company’s shares outstanding now amounts to $18.16 million, simultaneously with a float of $15.88 million. The organization now has a market capitalization sitting at $112.68 million. At the time of writing, stock’s 50-day Moving Average stood at $6.75, while the 200-day Moving Average is $10.27.
OptimizeRx Corp (OPRX) Ownership Facts and Figures
Now let’s turn our focus to how large-scale investors are working with this stock of the Health Information Services Industry. OptimizeRx Corp’s current insider ownership accounts for 13.35%, in contrast to 74.88% institutional ownership. According to the most recent insider trade that took place on Jan 09 ’24, this organization’s General Counsel and CCO sold 4,000 shares at the rate of 15.19, making the entire transaction reach 60,751 in total value, affecting insider ownership by 11,114.
OptimizeRx Corp (OPRX) Earnings and Revenue Records
OptimizeRx Corp’s EPS increase for this current 12-month fiscal period is 33.94% and is forecasted to reach 0.46 in the upcoming year.
OptimizeRx Corp (NASDAQ: OPRX) Trading Performance Indicators
Let’s observe the current performance indicators for OptimizeRx Corp (OPRX). It’s Quick Ratio in the last reported quarter now stands at 3.07. The Stock has managed to achieve an average true range (ATR) of 0.48. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.35.
In the same vein, OPRX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.00, a figure that is expected to reach 0.38 in the next quarter, and analysts are predicting that it will be 0.46 at the market close of one year from today.
Technical Analysis of OptimizeRx Corp (OPRX)
If we take a close look at the recent performances of OptimizeRx Corp (NASDAQ: OPRX), its last 5-days Average volume was 0.32 million that shows progress from its year to date volume of 0.13 million. During the previous 9 days, stock’s Stochastic %D was recorded 53.87% While, its Average True Range was 0.52.
Raw Stochastic average of OptimizeRx Corp (OPRX) in the period of the previous 100 days is set at 17.06%, which indicates a major fall in contrast to 61.25% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 88.73% that was higher than 60.61% volatility it exhibited in the past 100-days period.
